Research and Markets: Bioinformatics Analytical Software

DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 26, 2004--

The Market for Bioinformatics Analytical Software is Estimated to Reach $240M in 2004 and Growth Will Continue at a Moderate Compound Annual Rate of 9.3% to Reach Approximately $375M Worldwide in 2009

Research and Markets (http://www.researchandmarkets.com) has announced the addition of Bioinformatics Analytical Software to their offering.

Technological advancements in laboratory experimentation are fueling the need for bio informatics tools to capture, analyze, annotate, and store data, and, most importantly, extract meaningful biological information. Bioinformatics analytical software offers the possibility of improving the efficiency of every step in the drug-discovery process, from compound-library generation through hit finding to clinical trial management.

The market for bioinformatics analytical software is estimated to reach $240M in 2004 and growth will continue at a moderate compound annual rate of 9.3% to reach approximately $375M worldwide in 2009. In 2009, segment distribution within the market will be Genomics at 50%, Proteomics at 20%, Cheminformatics at 19%, and Pharmacogenomics at 11%.

This report includes in-depth analysis and end user perspectives on current bioinformatics software. The report also incorporates company profiles, trends and challenges, and strategic options for analytical software companies seeking to leverage market opportunities. The study provides financial models and the detailed assumptions used to determine major company market shares and the industry-wide revenue forecast.

Report Contents:

I. Executive Summary I-1

II. Objectives and Methodology II-1

III. Technical Overview III-1

IV. Bioinformatics Analytical Software Market IV-1

V. End User Analysis V-1

VI. Trends, Challenges, and Strategic Options VI-1

For more information visit http://www.researchandmarkets.com/reports/c4280